Seeking Alpha

The FDA is finalizing plans for a suicidality warning on 11 epilepsy drugs which topped $8B in...

The FDA is finalizing plans for a suicidality warning on 11 epilepsy drugs which topped $8B in sales last year. Companies affected include GSK, ABT, JNJ, NVS and PFE. The latter openly disputes the move.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|